Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.


home / news releases / MYOV - Myovant Sciences: Becoming A Blockbuster

MYOV - Myovant Sciences: Becoming A Blockbuster

Myovant Sciences Ltd.
  • Myovant recently cleared another regulatory binary for relugolix as a treatment for uterine fibroids.
  • On top of the clearance for advanced prostate cancer, Relugolix is now approved for two indications.
  • With COVID abating, you can anticipate relugolix sales to ramp up by multiple folds.

For further details see:

Myovant Sciences: Becoming A Blockbuster
Stock Information
Company Name: Myovant Sciences Ltd.
Stock Symbol: MYOV
Market: NYSE
Website: myovant.com
Menu
MYOV MYOV Quote MYOV Short MYOV News MYOV Articles MYOV Message Board
Get MYOV Alerts

News, Short Squeeze, Breakout and More Instantly...